Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 10 de 10
1.
Can J Physiol Pharmacol ; 99(12): 1324-1332, 2021 Dec.
Article En | MEDLINE | ID: mdl-34314655

We tested the hypothesis that ethanol would aggravate the deleterious effects of sub-lethal cecal ligation and puncture (SL-CLP) sepsis in the cardiorenal system and that inhibition of inducible nitric oxide synthase (iNOS) would prevent such response. Male C57BL/6 mice were treated with ethanol for 12 weeks. One hour before SL-CLP surgery, mice were treated with N6-(1-iminoethyl)-lysine (L-NIL, 5 mg/kg, i.p.), a selective inhibitor of iNOS. A second dose of L-NIL was administered 24 h after SL-CLP surgery. Mice were killed 48 h post surgery and the blood, the renal cortex, and the left ventricle (LV) were collected for biochemical analysis. L-NIL attenuated the increase in serum creatinine levels induced by ethanol, but not by SL-CLP. Ethanol, but not SL-CLP, increased creatine kinase (CK)-MB activity and L-NIL did not prevent this response. In the renal cortex, L-NIL prevented the redox imbalance induced by ethanol and SL-CLP. Inhibition of iNOS also decreased lipoperoxidation induced by ethanol and SL-CLP in the LV. L-NIL prevented the increase of pro-inflammatory cytokines and reactive oxygen species induced by ethanol and (or) SL-CLP in the cardiorenal system, suggesting that iNOS modulated some of the molecular mechanisms that underlie the deleterious effects of both conditions in the cardiorenal system.


Enzyme Inhibitors/pharmacology , Ethanol/adverse effects , Heart Ventricles/metabolism , Kidney Cortex/metabolism , Lysine/pharmacology , Nitric Oxide Synthase Type II/antagonists & inhibitors , Sepsis/etiology , Sepsis/prevention & control , Animals , Creatine Kinase, MB Form/metabolism , Creatinine/blood , Cytokines/metabolism , Enzyme Inhibitors/administration & dosage , Inflammation Mediators/metabolism , Lipid Peroxidation/drug effects , Lysine/administration & dosage , Male , Mice, Inbred C57BL , Nitric Oxide Synthase Type II/physiology , Reactive Oxygen Species/metabolism
2.
Am J Physiol Heart Circ Physiol ; 321(2): H275-H291, 2021 08 01.
Article En | MEDLINE | ID: mdl-34142885

Ethanol consumption represents a significant public health problem, and excessive ethanol intake is a risk factor for cardiovascular disease (CVD), one of the leading causes of death and disability worldwide. The mechanisms underlying the effects of ethanol on the cardiovascular system are complex and not fully comprehended. The gut microbiota and their metabolites are indispensable symbionts essential for health and homeostasis and therefore, have emerged as potential contributors to ethanol-induced cardiovascular system dysfunction. By mechanisms that are not completely understood, the gut microbiota modulates the immune system and activates several signaling pathways that stimulate inflammatory responses, which in turn, contribute to the development and progression of CVD. This review summarizes preclinical and clinical evidence on the effects of ethanol in the gut microbiota and discusses the mechanisms by which ethanol-induced gut dysbiosis leads to the activation of the immune system and cardiovascular dysfunction. The cross talk between ethanol consumption and the gut microbiota and its implications are detailed. In summary, an imbalance in the symbiotic relationship between the host and the commensal microbiota in a holobiont, as seen with ethanol consumption, may contribute to CVD. Therefore, manipulating the gut microbiota, by using antibiotics, probiotics, prebiotics, and fecal microbiota transplantation might prove a valuable opportunity to prevent/mitigate the deleterious effects of ethanol and improve cardiovascular health and risk prevention.


Alcohol Drinking/physiopathology , Cardiovascular Diseases/physiopathology , Dysbiosis/physiopathology , Gastrointestinal Microbiome , Alcohol Drinking/immunology , Anti-Bacterial Agents/therapeutic use , Anti-Infective Agents, Local , Cardiovascular Diseases/immunology , Cardiovascular Diseases/therapy , Dysbiosis/immunology , Dysbiosis/therapy , Ethanol , Fecal Microbiota Transplantation , Humans , Prebiotics , Probiotics/therapeutic use
3.
Can J Physiol Pharmacol ; 99(10): 1016-1025, 2021 Oct.
Article En | MEDLINE | ID: mdl-33887163

Overexpression of the inducible isoform of the enzyme nitric oxide synthase (iNOS) has been associated to pathological processes in the kidney. Ethanol consumption induces the renal expression of iNOS; however, the contribution of this enzyme to the deleterious effects of ethanol in the kidney remains elusive. We examined whether iNOS plays a role in the renal dysfunction and oxidative stress induced by ethanol consumption. With this purpose, male C57BL/6 wild-type (WT) or iNOS-deficient (iNOS-/-) mice were treated with ethanol (20% v/v) for 10 weeks. Treatment with ethanol increased the expression of Nox4 as well as the concentration of thiobarbituric acid reactive substances and the levels of tumor necrosis factor α in the renal cortex of WT but not iNOS-/- mice. Augmented serum levels of creatinine and increased systolic blood pressure were found in WT and iNOS-/- mice treated with ethanol. WT mice treated with ethanol showed increased production of reactive oxygen species and myeloperoxidase activity, but these responses were attenuated in iNOS-/- mice. We concluded that iNOS played a role in ethanol-induced oxidative stress and pro-inflammatory cytokine production in the kidney. These are mechanisms that may contribute to the renal toxicity induced by ethanol.


Alcohol Drinking/metabolism , Cytokines/metabolism , Ethanol/pharmacology , Inflammation/pathology , Kidney Diseases/pathology , Nitric Oxide Synthase Type II/metabolism , Alcohol Drinking/adverse effects , Alcohol Drinking/pathology , Animals , Anti-Infective Agents, Local/toxicity , Creatinine/metabolism , Inflammation/enzymology , Inflammation/metabolism , Inflammation Mediators/metabolism , Kidney Diseases/etiology , Kidney Diseases/metabolism , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Nitric Oxide Synthase Type II/biosynthesis , Oxidation-Reduction , Oxidative Stress/drug effects , Reactive Oxygen Species/metabolism
4.
Can J Physiol Pharmacol ; 99(7): 744-751, 2021 Jul.
Article En | MEDLINE | ID: mdl-33175570

We tested the hypothesis that ethanol consumption would aggravate the renal damage induced by cyclophosphamide (CYP). Male C57BL/6 J mice from control (n = 8) and CYP (n = 12) groups had free access to filtered water and standard rodent chow for 12 weeks. Then, 24 h before euthanasia mice received an intraperitoneal injection of saline or CYP (300 mg/kg). Mice from ethanol (n = 8) and CYP + ethanol (n = 12) groups had free access to increasing doses of ethanol for 12 weeks. Twenty-four hours before euthanasia, mice from ethanol and CYP + ethanol groups received an intraperitoneal injection of saline or CYP, respectively. Ethanol, CYP, or the association of both drugs augmented serum levels of creatinine and increased the levels of superoxide ([Formula: see text]) generation and thiobarbituric acid reactive substances in the renal cortex. Upregulation of Nox4 and increased activity of superoxide dismutase were detected in the renal cortex of mice treated with ethanol, CYP, or the combination of these drugs; however, these molecular alterations induced by CYP were not potentiated by ethanol consumption. Our findings revealed that chronic ethanol consumption had no potentiating effect on the nephrotoxic effects displayed by CYP. It is possible that the combination of these drugs showed no synergistic effect because they share the same molecular mechanisms of renal toxicity.


Ethanol , Animals , Cyclophosphamide , Male , Mice , Superoxides
5.
Cardiovasc Toxicol ; 21(3): 224-235, 2021 03.
Article En | MEDLINE | ID: mdl-33067693

Changes in redox state are described in the early stages of ethanol-induced cardiac toxicity. Here, we evaluated whether nebivolol would abrogate ethanol-induced redox imbalance in the heart. Male Wistar rats were treated with a solution of ethanol (20% v/v) for 3 weeks. Treatment with nebivolol (10 mg/kg/day; p.o. gavage) prevented the increase of both superoxide (O2•-) and thiobarbituric acid reactive substances (TBARS) in the left ventricle of rats chronically treated with ethanol. Neither ethanol nor nebivolol affected the expression of Nox4, p47phox, or Rac-1. Nebivolol prevented ethanol-induced increase of Nox2 expression in the left ventricle. Superoxide dismutase (SOD) activity as well as the concentration of reduced glutathione (GSH) was not altered by ethanol or nebivolol. Augmented catalase activity was detected in the left ventricle of both ethanol- and nebivolol-treated rats. Treatment with nebivolol, but not ethanol increased eNOS expression in the left ventricle. No changes in the activity of matrix metalloproteinase (MMP)2 or in the expressions of MMP2, MMP9, and tissue inhibitor metalloproteinase (TIMP)1 were detected after treatment with ethanol or nebivolol. However, ethanol increased the expression of TIMP2, and this response was prevented by nebivolol. Our results provided novel insights into the mechanisms underlying the early stages of the cardiac injury induced by ethanol consumption. We demonstrated that Nox2/NADPH oxidase-derived ROS play a role in ethanol-induced lipoperoxidation and that this response was prevented by nebivolol. In addition, we provided evidence that MMPs are not activated in the early stages of ethanol-induced cardiac toxicity.


Cardiomyopathy, Alcoholic/prevention & control , Heart Ventricles/drug effects , Lipid Peroxidation/drug effects , Myocytes, Cardiac/drug effects , NADPH Oxidase 2/metabolism , Nebivolol/pharmacology , Superoxides/metabolism , Animals , Cardiomyopathy, Alcoholic/enzymology , Cardiomyopathy, Alcoholic/etiology , Cardiomyopathy, Alcoholic/pathology , Catalase/metabolism , Disease Models, Animal , Ethanol , Heart Ventricles/enzymology , Heart Ventricles/pathology , Male , Myocytes, Cardiac/enzymology , Myocytes, Cardiac/pathology , Nitric Oxide Synthase Type III/metabolism , Rats, Wistar , Tissue Inhibitor of Metalloproteinase-2/metabolism , Up-Regulation
6.
Life Sci ; 242: 117239, 2020 Feb 01.
Article En | MEDLINE | ID: mdl-31901444

AIMS: Reactive oxygen species (ROS) and pro-inflammatory cytokines play a critical role in organ damage induced by ethanol consumption. Interleukin (IL)-10 maintain tissue homeostasis through restriction of excessive inflammatory responses and inhibition of ROS generation. These responses limit unnecessary tissue damage in the cardiorenal system. We hypothesized that IL-10 would limit the deleterious effects induced by ethanol consumption in the cardiorenal system. MATERIALS AND METHODS: Male C57BL/6J wild-type (WT) or IL10-deficient mice (IL-10-/-) were treated with ethanol (20% v/v) for 6 weeks. KEY FINDINGS: IL-10 deficiency was associated with an increased mortality rate. Ethanol consumption decreased plasma levels of IL-10 in WT mice. Increased levels of IL-6 were detected in the aorta from IL-10-deficient mice, but not WT mice. No alterations in the levels of urea, creatinine, sodium, potassium or creatine kinase (CK)-MB were found after treatment with ethanol. Augmented concentration of thiobarbituric acid reactive substances (TBARS) was found in the left ventricle (LV) of IL-10-deficient mice, but not WT mice. Increased levels of superoxide anion (O2-) were found in the renal cortex of both WT and IL-10-deficient mice. Renal cortex from WT mice chronically treated with ethanol showed decreased levels of H2O2. No changes in the expression of Nox1, Nox4 or catalase were found in the renal cortex from ethanol-treated mice. SIGNIFICANCE: IL-10 limited the production of ROS and the synthesis of pro-inflammatory cytokines induced by ethanol in the cardiorenal system. These findings provided novel evidence that IL-10 counteracted the initial mechanisms whereby ethanol induces its cardiorenal damages.


Ethanol/adverse effects , Heart/drug effects , Interleukin-10/metabolism , Kidney/drug effects , Acute Kidney Injury/chemically induced , Animals , Blotting, Western , Creatine Kinase, MB Form/blood , Creatinine/blood , Interleukin-10/blood , Interleukin-10/physiology , Male , Mice , Mice, Inbred C57BL , Potassium/blood , Sodium/blood , Urea/blood
7.
Nitric Oxide ; 94: 19-26, 2020 01 01.
Article En | MEDLINE | ID: mdl-31610241

Hypertension is a risk factor for erectile dysfunction (ED) and both conditions are associated with oxidative stress. Given that nitrite is described to display antioxidant effects, we hypothesized that treatment with nitrite would exert antioxidant effects attenuating both reactive oxygen species (ROS) generation in the corpora cavernosa (CC) and ED induced by hypertension. Two kidney, one clip (2K1C) hypertension was induced in male Wistar rats. Treatment with sodium nitrite (15 mg/kg/day, p.o., gavage) was initiated two weeks after surgery to induce hypertension and maintained for four weeks. Nitrite abrogated both the decrease in intracavernosal pressure and endothelial dysfunction of the CC induced by hypertension. Treatment with nitrite decreased hypertension-induced ROS generation in the CC assessed in situ using the fluorescent dye dihidroethidium (DHE) and with the lucigenin assay. Western immunoblotting analysis revealed that nitrite prevented the increase in Nox1 expression in the CC from 2K1C rats. Decreased concentrations of hydrogen peroxide (H2O2) were found in the CC from hypertensive rats and treatment with nitrite prevented this response. Treatment with nitrite increased the fluorescence of DAF-2DA in the CC from sham-operated rats and restored nitric oxide (NO) levels in the CC from 2K1C rats. In summary, we found novel evidence that nitrite reversed the decrease in intracavernosal pressure induced by 2K1C hypertension. This response was partially attributed to the antioxidant effect of nitrite that blunted ROS generation and endothelial dysfunction in the CC. In addition, nitrite-derived NO may have promoted direct protective actions against hypertension-induced CC dysfunction.


Erectile Dysfunction/drug therapy , Hypertension/drug therapy , Penis/drug effects , Reactive Oxygen Species/antagonists & inhibitors , Animals , Antihypertensive Agents , Antioxidants , Erectile Dysfunction/metabolism , Hypertension/metabolism , Male , Nitrites , Penis/metabolism , Rats , Rats, Wistar , Reactive Oxygen Species/metabolism
8.
Alcohol Alcohol ; 55(1): 3-10, 2020 Feb 07.
Article En | MEDLINE | ID: mdl-31845992

AIMS: We investigated the cardiac effects of ethanol withdrawal and the possible role of AT1 receptors in such response. METHODS: Male Wistar rats were treated with increasing doses of ethanol (3 to 9%, vol./vol.) for 21 days. The cardiac effects of ethanol withdrawal were investigated 48 h after abrupt discontinuation of ethanol. Some animals were orally treated with losartan (10 mg/kg/day), a selective AT1 receptor antagonist. RESULTS: Ethanol withdrawal did not affect serum levels of creatine kinase (CK)-MB. Losartan prevented ethanol withdrawal-induced increase in superoxide anion (O2•-) production in the left ventricle (LV). However, ethanol withdrawal did no alter the levels of thiobarbituric acid reactive substances (TBARS) or the expression of Nox1, Nox2 or Nox4 were found in the LV. Ethanol withdrawal reduced the concentration of hydrogen peroxide (H2O2) in the LV and this response was prevented by losartan. Ethanol withdrawal increased catalase activity in the LV and losartan attenuated this response. No changes on superoxide dismutase (SOD) activity or expression were detected in the LV during ethanol withdrawal. The expression of AT1, AT2 or angiotensin converting enzyme (ACE) was not affected by ethanol withdrawal. Similarly, no changes on the expression of ERK1/2, SAPK/JNK, COX-1 or COX-2 were found in the LV during ethanol withdrawal. CONCLUSIONS: Ethanol withdrawal altered the cardiac oxidative state through AT1-dependent mechanisms. Our findings showed a role for angiotensin II/AT1 receptors in the initial steps of the cardiac effects induced by ethanol withdrawal.


Ethanol/adverse effects , Heart Ventricles/metabolism , Receptor, Angiotensin, Type 1/biosynthesis , Substance Withdrawal Syndrome/metabolism , Superoxides/metabolism , Animals , Catalase/metabolism , Creatine Kinase, MB Form/blood , Cyclooxygenase 1/biosynthesis , Cyclooxygenase 2/biosynthesis , Hydrogen Peroxide/metabolism , Losartan/pharmacology , Male , Membrane Proteins/biosynthesis , Mitogen-Activated Protein Kinase 1/biosynthesis , Mitogen-Activated Protein Kinase 3/biosynthesis , Mitogen-Activated Protein Kinase 8/biosynthesis , NADPH Oxidases/biosynthesis , Peptidyl-Dipeptidase A/biosynthesis , Rats , Receptor, Angiotensin, Type 2/biosynthesis , Substance Withdrawal Syndrome/blood , Substance Withdrawal Syndrome/prevention & control , Superoxide Dismutase/metabolism , Thiobarbituric Acid Reactive Substances/metabolism
9.
Eur J Pharmacol ; 863: 172706, 2019 Nov 15.
Article En | MEDLINE | ID: mdl-31568782

It is well established that sepsis induces vascular hyporesponsiveness to vasoconstrictors. Perivascular adipose tissue (PVAT) displays anti-contractile action in various blood vessels. We hypothesized that sepsis would increase the anti-contractile effect of PVAT aggravating sepsis-induced vasoplegia. Male Wistar Hannover rats were subjected to lethal sepsis by cecal ligation and puncture (CLP) method. Aorta or PVAT were collected for functional or biochemical assays 6 h after CLP surgery. Functional experiments showed that sepsis increased the anti-contractile action of PVAT in both endothelium-intact and endothelium-denuded aortas. Carboxy-PTIO, L-NAME and ODQ reversed the hypocontractility mediated by PVAT in aortas from septic rats. Inhibition of nNOS and iNOS with 7-nitroindazole and 1400 W attenuated PVAT-mediated hypocontractility during sepsis. Similar results were found in the presence of indomethacin and Ro1138452, a selective prostacyclin IP receptor antagonist. However, neither tiron nor catalase affected phenylephrine-induced contraction in aortas from septic rats. Increased levels of superoxide anion (O2•-) and 6-keto-prostaglandin F1α (stable product of prostacyclin) were detected in PVAT from septic rats. In situ quantification of reactive oxygen species and nitric oxide (NO) using fluorescent dyes revealed increased levels of both in PVAT from septic rats. The novelty of our study is that PVAT contributes to sepsis-induced vasoplegia by releasing NO and prostacyclin. These findings suggested that signaling pathways in PVAT may be considered as potential novel pharmacological therapeutic targets during sepsis-induced vasoplegia.


Adipose Tissue/pathology , Sepsis/complications , Vasoplegia/etiology , Vasoplegia/pathology , 6-Ketoprostaglandin F1 alpha/metabolism , Adipose Tissue/metabolism , Animals , Aorta/pathology , Dinoprostone/metabolism , Male , Nitric Oxide/biosynthesis , Rats , Rats, Wistar , Reactive Oxygen Species/metabolism , Superoxide Dismutase/metabolism , Vasoplegia/metabolism
10.
Cytokine ; 121: 154734, 2019 09.
Article En | MEDLINE | ID: mdl-31151047

We evaluated the role of tumor necrosis factor (TNF)-α receptor 1 (TNFR1) on ethanol-induced cardiac dysfunction. Male C57BL/6J wild-type (WT) or TNFR1-deficient mice (TNFR1-/-) were treated with ethanol (20% v/v) for 10 weeks. Increased protein expression of TNFR1 and NFκB p65 was detected in the left ventricle (LV) of WT mice chronically treated with ethanol. Echocardiographic analysis showed that ethanol consumption increased left ventricular posterior wall end-diastolic diameter and left ventricular posterior wall end-systolic diameter in WT, but not TNFR1-/- mice. Increased levels of TNF-α, interleukin (IL)-6, superoxide anion (O2-), thiobarbituric acid reactive substances (TBARS) as well as increased nitrotyrosine immunostaining were detected in the LV from WT, but not TNFR1-/- mice. Conversely, treatment with ethanol decreased nitrate/nitrite (NOx) concentration in the LV. Histopathological analysis showed that ethanol did not induce inflammatory infiltrates, necrosis or edema in the LV. No differences in the ventricular expression of iNOS, Nox2 or COX-2 as well as in the activity of superoxide dismutase (SOD), myeloperoxidase (MPO) and N-acetyl-beta-D-glucosaminidase (NAG) were found after treatment with ethanol. Our study provided novel evidence that ethanol consumption augmented the production of reactive oxygen species (ROS) and the synthesis of pro-inflammatory proteins in the LV through TNFR1-dependent mechanisms. These findings provided novel mechanistic insights about the contribution of TNFR1 in the initial steps of the cardiac damage induced by ethanol.


Alcohol Drinking/metabolism , Ethanol/adverse effects , Inflammation Mediators/metabolism , Myocardium/metabolism , Myocardium/pathology , Receptors, Tumor Necrosis Factor, Type I/metabolism , Acetylglucosaminidase/metabolism , Animals , Catalase/metabolism , Chronic Disease , Cytokines/metabolism , Electrocardiography , Glutathione/metabolism , Heart Function Tests , Heart Ventricles/enzymology , Heart Ventricles/pathology , Male , Mice, Inbred C57BL , Nitrates/metabolism , Nitrites/metabolism , Nitrosation , Oxidative Stress , Peroxidase/metabolism , Reactive Oxygen Species/metabolism , Superoxide Dismutase/metabolism , Thiobarbituric Acid Reactive Substances/metabolism
...